Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Clinical Outcomes with Eculizumab and Ravulizumab in Anti-aquaporin-4 Antibody-positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Results from the Global NMO SPOTLIGHT Registry

Evaluating the Therapeutic Potential of Lacosamide in Migraine Using a Cortical Spreading Depolarization Model

Ofatumumab Treatment Up to Eight Years Shows a Favorable and Consistent Safety Profile in People Living With Relapsing Multiple Sclerosis